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ABSTRACT: Pseudomonas aeruginosa is an opportunistic
human pathogen recognized as a critical threat by the World
Health Organization because of the dwindling number of
eﬀective therapies available to treat infections. Over the past
decade, it has become apparent that the glyoxylate shunt plays
a vital role in sustaining P. aeruginosa during infection
scenarios. The glyoxylate shunt comprises two enzymes:
isocitrate lyase and malate synthase isoform G. Inactivation of
these enzymes has been reported to abolish the ability of P.
aeruginosa to establish infection in a mammalian model system, yet we still lack the structural information to support drug design
eﬀorts. In this work, we describe the ﬁrst X-ray crystal structure of P. aeruginosa malate synthase G in the apo form at 1.62 Å
resolution. The enzyme is a monomer composed of four domains and is highly conserved with homologues found in other
clinically relevant microorganisms. It is also dependent on Mg2+ for catalysis. Metal ion binding led to a change in the intrinsic
ﬂuorescence of the protein, allowing us to quantitate its aﬃnity for Mg2+. We also identiﬁed putative drug binding sites in malate
synthase G using computational analysis and, because of the high resolution of the experimental data, were further able to
characterize its hydration properties. Our data reveal two promising binding pockets in malate synthase G that may be exploited
for drug design.
Malate synthase isoform G (MS) is the second enzyme ofthe glyoxylate shunt, which is an anaplerotic pathway
that diverts carbon skeletons away from the catabolic reactions
of the tricarboxylic acid cycle by providing a route from
isocitrate directly to gluconeogenic precursors.1 The glyoxylate
shunt is present in a wide range of prokaryotic and lower
eukaryotic organisms1,2 and allows the synthesis of cell
constituents from metabolic inputs containing (or metabolized
to) a C2 backbone, such as fatty acids, acetate, or ethanol.
Instead of undergoing oxidative decarboxylation to yield α-
ketoglutarate, ﬁrst isocitrate is cleaved to yield glyoxylate and
succinate in a reversible reaction catalyzed by isocitrate lyase
(ICL). Thereafter, MS catalyzes the second reaction in the
glyoxylate shunt, which is the irreversible condensation of
glyoxylate and acetyl-coenzyme A (AcCoA) to yield coenzyme
A (CoA) and malate.
The shunt enzymes have been implicated in virulence,
persistence, and antibiotic resistance in several medically
relevant organisms,2−5 including the opportunistic pathogen
Pseudomonas aeruginosa (PA). PA is a Gram-negative bacillus
that has been reported to occupy a variety of ecological niches.6
It is also a notorious nosocomial pathogen, accounting for 15%
of hospital infections.6−8 These infections escalate the need for
surgical intervention, increase the overall length and costs of
hospitalization, and can carry an average mortality rate of 60%.9
PA is also associated with certain types of chronic infection,
most notably in the airways of patients with cystic ﬁbrosis.10
These infections are often especially diﬃcult to resolve because
of the high acquired and intrinsic antibiotic resistance of PA.
Certainly, the lack of new anti-Pseudomonal drugs available to
the clinical community recently led the World Health
Organization to classify PA as a “Priority 1: Critical” pathogen
for the development of new antibiotics.11
Expression levels of the glyoxylate shunt enzymes are
upregulated in chronic PA infections of cystic ﬁbrosis
patients.12,13 Additionally, ICL and MS appear to be vital for
ﬁtness of PA in mammalian infection models. An ICL deletion
mutant displayed an increased rate of clearance from the lung
and a reduced level of tissue damage in a rat pulmonary
infection model.2,14 Likewise, a PA double mutant (ΔICL
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ΔMS) was found to be completely avirulent in a mouse
pulmonary infection model.15 Thus, both ICL and MS are
attractive targets for drug discovery because they are essential
during infection situations. Crucially, no orthologs of the shunt
enzymes exist in humans.4 Examination of the crystal structures
of shunt enzymes from Mycobacterium tuberculosis (Mtb)
suggested that MS would provide a more druggable target
than ICL would because of its deeper, more hydrophobic active
site, which has to accommodate the pantothenate tail of
AcCoA.16,17 Moreover, drugs that target the shunt enzymes
have potential as broad spectrum antibiotics given their
conservation across many pathogenic species.18
In this work, we present the 1.62 Å resolution structure of
malate synthase G from P. aeruginosa. We then use this
structural data to identify and describe the most suitable
binding pockets for drug development in this critical priority
pathogen. Furthermore, we use molecular dynamic simulation
to yield the free energy of bound water molecules, mapping the
likely physiological hydration network of the protein.
■ EXPERIMENTAL PROCEDURES
Cloning, Overexpression, and Puriﬁcation. MS (GlcB,
PA0482) from P. aeruginosa strain PAO1 was overexpressed
with a Precission protease-cleavable, N-terminal GST tag. A 2 L
culture of Escherichia coli strain BL21 containing plasmid
[pGEX-6P-1 (glcB)]19 was grown with good aeration at 37 °C
in 2×TY medium to an OD600 of 0.6. The temperature was
then decreased to 16 °C; IPTG was added to a ﬁnal
concentration of 0.1 mM to induce expression of the cloned
glcB ORF, and protein expression was continued for a further
16 h. The cells were harvested by centrifugation (3430g for 30
min at 4 °C), and the cell pellets were resuspended in 30 mL of
ice-cold lysis buﬀer (phosphate-buﬀered saline supplemented
with 1 mM DTT and an EDTA-free protease inhibitor cocktail
tablet). The cells were lysed to completion by sonication on ice.
Cell debris was removed by centrifugation (15000g for 30 min
at 4 °C), and the supernatant was ﬁltered through a 0.45 μm
membrane ﬁlter. Subsequent puriﬁcation was performed using
an ÄKTA FPLC system. The ﬁltered sample was loaded
immediately onto a 5 mL glutathione sepharose column
(GSTrapFF) equilibrated with buﬀer A [150 mM NaCl, 50
mM Tris-HCl, 1 mM EDTA, and 0.1 mM TCEP (pH 7.5)].
The column was washed with buﬀer A, and the bound protein
was eluted with buﬀer A supplemented with reduced
glutathione (10 mM). Meanwhile, 5 mL of slurried glutathione
Sepharose 4B resin (GE Healthcare) was equilibrated with
buﬀer A in a 50 mL polypropylene tube. The GST-tagged MS
fusion protein was added to the glutathione sepharose beads
along with 50 units of PreScission Protease (GE Healthcare).
The mixture was then incubated for 48 h at 4 °C while being
gently mixed to allow cleavage of the fusion protein from the
immobilized GST tag. The supernatant was loaded directly
onto a 16-600 Superdex 200 preparatory grade column (GE
Healthcare) equilibrated with buﬀer A. The ﬂow rate was 0.8
mL min−1, and the eluate was collected in 2 mL fractions.
Fractions containing puriﬁed MS were pooled, concentrated,
frozen in liquid nitrogen, and stored at −80 °C. The protein
concentration was determined by spectrophotometry using the
calculated molar extinction coeﬃcient for PA MS (εcalc = 75985
M−1 cm−1).
Preparation of Mg2+-Depleted MS. After batch puriﬁca-
tion, 50 mM EDTA was added to a portion of puriﬁed MS to
remove bound metals for ﬂuorescence studies. MS was then
dialyzed extensively at 4 °C in 50 mM Tris-HCl (pH 7.5)
containing 100 mM NaCl and 10 mM EDTA. The EDTA was
then removed by dialysis at 4 °C against 3 × 1 L of 50 mM
Tris-HCl (pH 7.5) containing 100 mM NaCl. The ﬁnal protein
concentration was adjusted to 175 μM after dialysis.
Kinetic Measurements of MS. The enzymatic activity of
MS was measured using a modiﬁed coupled assay in which the
amount of free thiol (present in the reaction product, CoA) was
titrated using 5,5′-dithio(2-nitrobenzoic acid) (DTNB).19
Brieﬂy, reaction mixtures contained buﬀer [50 mM dipotassium
phosphate and 15 mM MgCl2 (pH 7.5)] supplemented with
AcCoA and glyoxylate (as indicated) and 0.2 mM DTNB. The
mixture was equilibrated at 37 °C for 1 min before the reaction
was initiated by addition of MS (ﬁnal concentration of 25 nM).
The initial linear change in absorbance (ΔAbs) was recorded at
412 nm using a Biospectrometer (Eppendorf). Rates were
calculated using the molar extinction coeﬃcient of DTNB
(14150 M−1 cm−1). Kinetic parameters were calculated from
best-ﬁt nonlinear regression using GraphPad Prism version 6.
Crystallization of MS. Crystallization conditions were
screened using sitting drop vapor diﬀusion with ≥11 mg/mL
puriﬁed protein. The best crystals were obtained with a 1:1
mixture of protein and reservoir solution [0−25 mM
ammonium sulfate, 13−17% (v/v) glycerol, and 20−27% (w/
v) PEG 4000] at 19 °C. Crystals were grown for 2−6 days,
treated with a cryoprotectant [24% (v/v) ethylene glycol and
76% (v/v) mother liquor], mounted in nylon loops, and ﬂash-
frozen in liquid nitrogen prior to data collection.
X-ray Diﬀraction, Structure Determination, and
Reﬁnement. Diﬀraction data were collected remotely on
beamline MX-I03 at the Diamond Light Source Synchrotron
(DLS, Didcot, U.K.). Diﬀraction data were processed using
Xia3 DIALS, and the structure was determined by molecular
replacement using Phaser.20 We used the apo MS structure
from Mtb (PDB entry 1N8I) as a model. Automated
reﬁnement was performed using PHENIX.reﬁne.21 Manual
modeling and reﬁnement were performed in COOT.22 Data
collection and reﬁnement statistics are listed in Table 1.
Fluorimetry. Fluorescence spectra were recorded on a
PerkinElmer LS55 luminescence spectrometer using an optical
cuvette with a 1 cm path length. Mg2+-depleted MS was added
to a buﬀer composed of 50 mM Tris-HCl (pH 7.5) and 100
mM NaCl, giving a ﬁnal MS concentration of 0.88 μM. MgCl2,
glyoxylate, and AcCoA were added to give the ﬁnal indicated
concentrations. The mixtures were equilibrated at 25 °C for 2
min prior to measurement. An excitation wavelength of 295 nm
was used for measurement of intrinsic tryptophan ﬂuorescence,
and the emission spectra were recorded between 300 and 400
nm. The excitation and emission slit widths were 2.5 nm. The
data presented are the mean of three independent repeats.
Computational Analysis of MS. The Schrödinger suite
(Schrödinger, LLC, New York, NY) was used for all
computations. Protein Preparation Wizard with default
parameters was used to prepare the MS structure for
downstream in silico analyses.23 SiteMap was used to predict
putative binding pockets. This algorithm predicts binding
pockets in proteins on the basis of the geometry, size, volume,
and nature (hydrophilicity/hydrophobicity) of amino acid
residues.24 SiteMap predicts druggable pockets and ranks
them using two parameters: the SiteScore and the druggability
or “Dscore”. SiteScore reveals highly promising binding sites in
the protein that can potentially be targeted with drugs, and
Dscore indicates the druggability of the predicted site. SiteMap
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was run using a ﬁne grid option with a more restrictive
deﬁnition of hydrophobicity to exclude solvent-exposed regions
during binding site prediction.
The solvation network plays an important role in
determining protein−ligand binding aﬃnity and may be useful
when designing or conducting virtual screening of potential
inhibitors. Probable hydration sites and associated thermody-
namic properties were predicted using the WaterMap
module.25 WaterMap predicts hydration sites and their
properties in user-deﬁned regions on the basis of molecular
dynamics. WaterMap was run using default parameters to
understand the druggability of MS through its solvation
network.
■ RESULTS AND DISCUSSION
Kinetic Analysis. Puriﬁed PA MS exhibited Michaelis−
Menten kinetics for glyoxylate and AcCoA substrates (Figure
1). The relevant steady state kinetic parameters are listed in
Table 2. Kinetic analysis of puriﬁed PA MS has been performed
in just one study, which reported a lower substrate aﬃnity for
glyoxylate and a higher substrate aﬃnity for AcCoA.19 Results
from kinetic analyses of other MSs from Mtb, E. coli, and
Corynebacterium glutamicum were comparable (Table 2).26−28
Additionally, Roucourt et al.19 have determined that the PA MS
enzymatic reaction proceeds through a sequential mechanism,
as opposed to a substituted mechanism.
Amino Acid Sequence Alignment. We aligned MS
amino acid sequences sourced from the Uniprot database (P.
aeruginosa, Q9I636; E. coli, P37330; M. tuberculosis, P9WK17;
Table 1. Summary of Data Collection and Reﬁnement
Statistics for P. aeruginosa Malate Synthase G
Data Collectiona
X-ray source DLS MX-I03
wavelength (Å) 0.97625
resolution range (Å) 71.17−1.62
total no. of reﬂections 556009 (9988)
no. of unique reﬂections 96326 (3151)
multiplicity 5.8 (3.2)
completeness (%) 94.5 (69.9)
mean I/σ(I) 11.75 (1.47)
Rsym 0.066 (0.912)
Rmeas 0.079 (1.080)
CC1/2 1 (0.5)
space group P212121
unit cell
a (Å) 71.17
b (Å) 81.2
c (Å) 137.57
α = β = γ (deg) 90
no. of molecules per asymmetric unit 1
Reﬁnement
Rwork (%) 16.7
Rfree (%) 19.6
no. of atoms
protein 6350
glycerol 4
1,2-ethanediol 15
ions 2
water 691
root-mean-square deviation
bond lengths (Å) 0.0008
bond angles (deg) 0.897
Wilson B factor (Å2) 19.6
average B factor (Å2)
overall 27.30
protein 25.49
glycerol 56.28
1,2-ethanediol 60.92
ions 54.90
water 38.76
Ramachandran analysis (%)
favored 98
allowed 1.9
outliers 0.1
rotamer outliers 0.3
MolProbity Clashscore 5
PDB entry 5OAS
aValues for the highest-resolution shell are given in parentheses.
Figure 1. Michaelis−Menten kinetics of P. aeruginosa malate synthase
G. Enzyme activity was measured by ﬁxing the concentration of one
substrate [either AcCoA (A) or glyoxylate (B)] at 0.2 mM and varying
the concentration of the second substrate as indicated. Each assay was
performed in triplicate. Error bars correspond to ±1 standard
deviation.
Table 2. Comparison of Kinetic Parameters of MS from
Other Microorganisms
organism
Km,gly
(μM)
Km,AcCoA
(μM)
Vmax
(μmol mg−1 s−1) ref
P. aeruginosa 34 47 1200 this work
P. aeruginosa 70 12 990 19
M. tuberculosis 30 10 23 (kcat) 28
M. tuberculosis 57 30 360 26
E. coli 21 9 2160 27
C. glutamicum 30 12 − 29
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Mycobacterium leprae, O32913) with Clustal Omega30,31 and
displayed the alignment with Jalview32 (Figure 2). There is 60%
sequence identity between PA and E. coli MS and 70%
sequence identity between PA and Mtb MS. The amino acid
residues that are identical among all four species are highlighted
in purple, and the residues known to be involved in catalysis in
Mtb and E. coli are highlighted in orange.26−28,33 We also
compared amino acid identity within a larger group of
pathogenic organisms that encode MS, signifying the evolu-
tionary relationship of MS in other medically relevant
organisms (Figures S1 and S2).
Tertiary Structure of MS. We crystallized PA MS and
determined the three-dimensional structure by molecular
replacement using Mtb MS (PDB entry 1N8I) as a template.
PA MS crystallized with one molecule in the asymmetric unit.
Consistent with this, MS also behaved as a monomer in
solution (Figure S3). The model (Figure 3) was optimized with
an Rwork of 16.7% and an Rfree of 19.6%. The Ramachandran
distribution of all amino acid residue dihedral angles in the
protein structure indicates that 98% of the amino acids are in
favored or allowed regions (Figure S4). The structure of MS in
the apo, substrate-bound, or product-bound form from three
other prokaryotic species has been elucidated by X-ray
crystallography: E. coli (PDB entries 1P7T and 2JQX), Mtb
(PDB entries 1N8W, 1N8I, and 2GQ3), and M. leprae (PDB
Figure 2. Amino acid sequence alignment of P. aeruginosa malate synthase G with homologues whose structures have been determined by X-ray
crystallography: E. coli, P37330, PDB entry 1P7T; M. tuberculosis, P9WK17, PDB entry 1N8I; M. leprae, O32913, PDB entry 4EX4. Amino acids are
colored by sequence identity, where regions of 100% sequence identity are highlighted in purple. Amino acids known to be involved in catalysis in E.
coli and M. tuberculosis are highlighted in orange; these are conserved among all four organisms shown.
Figure 3. Cartoon representation of malate synthase G from P.
aeruginosa (PDB entry 5OAS). The TIM barrel, α-helical, and β-sheet-
rich domains are colored blue, green, and red, respectively. The N-
terminus (amino acids 2−115) is colored light cyan. A closer look at
the active site shows the proposed substrate binding residues, Glu432
and Asp460, depicted as magenta sticks and the proposed catalytic
residues, Asp631 and Arg340, shown as orange sticks. The residues
involved in catalysis are oriented around a Mg2+ ion, which is depicted
as a chartreuse sphere.
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entry 4EX4). In addition, while our manuscript was in
preparation, we became aware that a structure of P. aeruginosa
MS with glyoxylate bound in the active site had been deposited
in the PDB (entry 5VFB). However, to the best of our
knowledge, this structure has not yet been described in the
literature. In common with these previously reported MS
structures, PA MS is composed of three domains: a TIM barrel
domain with eight α-helices and eight β-strands (amino acids
116−135 and 266−589), a helical domain (amino acids 590−
725), and a β-sheet-rich domain (amino acids 136−265)
inserted between the ﬁrst α-helix and second β-sheet of the
TIM barrel domain. Near the N-terminus of the protein is a
strikingly long α-helix (amino acids 32−71) that partially wraps
around the TIM barrel domain (Figure 3).
Comparison of the structure presented here with known
structures of MS from other organisms revealed that the active
site residues and the Mg2+ ion are highly conserved across
species.26,27,33−37 For example, the backbone rmsd of the
superposition between the Mtb MS used as the molecular
replacement template (PDB entry 1N8I) and PA MS is 0.94 Å
over 682 Cα atoms, and among the active site residues, the
rmsd is 0.20 Å. The active site sits between the TIM barrel and
a loop (amino acids 615−631 in PA) from domain II, and the
known active site residues are present in the PA MS structure in
the same positions (not shown). The active sites compared
between apo and substrate-bound crystal structures of MS are
practically identical, except for the tightening of the
aforementioned loop from domain II when glyoxylate is
bound (not shown), so MS is generally not considered to
undergo major conformational changes during catalysis.35
Additionally, comparison of the apo structure presented here
with the glyoxylate-bound structure of PA MS recently
deposited in the PDB (entry 5VFB) revealed no conforma-
tional diﬀerences except for a small shift in the solvent-exposed
loop (amino acids 305−312) far from the active site.
Inﬂuence of Mg2+ on Substrate Binding and the
Active Site Environment. The PA MS crystal structure
revealed electron density in the F0 − Fc diﬀerence map for a
Mg2+ ion and a molecule of ethylene glycol (EDO), the
cryoprotectant used when mounting MS crystals, in the active
site. Mg2+ is reportedly essential for the enzymatic function of
MS and is present in every MS crystal structure published. In
these other structures, the Mg2+ is coordinated by four water
molecules and conserved Glu and Asp residues in an octahedral
conformation.26,27,35,36,38,39 However, in our structure, the
Mg2+ appears to be coordinated by the EDO molecule, one
water molecule, and the side chains of Glu432, Asp460, Glu274,
and Asp275 (Figure 4). These amino acids contain carboxylate
groups, all located within 3.5 Å of the metal ion, and could be
interacting to decrease the overall energy. We also observed a
nearby conserved tryptophan residue (Trp539 in our
structure), which could be used as a ﬂuorescent reporter to
monitor metal ion binding in the active site. To test this, we
measured the intrinsic tryptophan ﬂuorescence of PA MS to
quantify the binding aﬃnity of Mg2+ and to examine the eﬀect
of the substrate(s) on Mg2+ binding.
To investigate the Mg2+ binding properties of PA MS, we
ﬁrst removed any prebound Mg2+ from the puriﬁed protein. We
observed a change in relative tryptophan ﬂuorescence intensity
and λmax upon addition of Mg
2+ and substrates to demetallized
MS. We determined λmax for demetallized MS as 340 nm, which
was red-shifted to 342 nm upon addition of 10 mM MgCl2
(Figure 5A). This indicates that the environment around the
tryptophan residue(s) becomes more hydrophilic and solvent-
exposed in the presence of Mg2+. Conversely, λmax was blue-
shifted to 337 nm after the addition of 1 mM glyoxylate (in the
presence of 10 mM MgCl2), indicating that the environment
around Trp539 becomes more hydrophobic and less exposed
to the bulk solvent. However, when 1 mM glyoxylate was added
to demetallized MS in the absence of added Mg2+, there was no
deviation in λmax or ﬂuorescence intensity compared with the
spectrum of the demetallized protein alone, implying that Mg2+
is needed in the active site for glyoxylate to bind (Figure S5A).
Interestingly, a comparison of the structure described here
with that of PA MS with bound glyoxylate (PDB entry 5VFB)
Figure 4. Mg2+ is coordinated by Glu274, Asp275, Glu432, Asp460,
ethylene glycol (EDO), and a single water molecule in the active site
of P. aeruginosa malate synthase G. The electron density map is
contoured at 1.5σ. Trp539 is located ∼6 Å from the Mg2+ in the crystal
structure (PDB entry 5OAS).
Figure 5. (A) Fluorescence spectra of demetallized malate synthase G
(black line), demetallized malate synthase G with 10 mM Mg2+ added
(blue dashes), and demetallized malate synthase G with 10 mM Mg2+
and 1 mM glyoxylate added (red dots). The λmax for each spectrum is
indicated by a vertical dashed line of the corresponding color. (B)
Stern−Volmer analyses indicate no global conformational changes as a
result of binding of Mg2+ or glyoxylate to malate synthase G. Error
bars correspond to ±1 standard deviation.
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reveals no apparent conformational diﬀerences between the
active sites. Together with the results outlined here, this is
consistent with physical occlusion of the bulk solvent in the
active site by the substrate. To establish whether binding of
Mg2+ or glyoxylate to PA MS is accompanied by global
conformational changes, we measured the accessibility of the
tryptophan residues to an extrinsic neutral quencher,
acrylamide. The presence of increasing concentrations of
acrylamide caused progressively stronger quenching of
tryptophan ﬂuorescence, but the apparent dynamic quenching
constant (KSV = 10.5 ± 0.2 M
−1) was similar for demetallized
MS and for Mg2+-bound or glyoxylate-bound MS (Figure 5B).
This indicates that the changes in tryptophan ﬂuorescence
arising from Mg2+ or glyoxylate binding arise as a consequence
of changes in the local microenvironment of one or more Trp
residues, most likely Trp539, in the active site. We also
examined whether the secondary structure content of the
protein was altered in the presence of its substrates using
circular dichroism (Figure S6). In contrast to a previous study,
we found no apparent changes in ellipticity upon addition of
the substrates to native MS.40
Adding AcCoA to demetallized MS prior to Mg2+ or
glyoxylate yielded no change in ﬂuorescence intensity or λmax
(Figure S5B). However, when a saturating concentration of
AcCoA was added after Mg2+ and glyoxylate, the spectrum
recovered to that of the Mg2+-bound spectrum. This is
consistent with a sequential reaction mechanism in which
glyoxylate binding is a prerequisite for acetyl-CoA binding, and
that Mg2+ remains bound in the active site upon release of the
reaction products.19,26−29,34,38−40
The enhancement in MS tryptophan ﬂuorescence following
addition of Mg2+ suggested that this spectroscopic signal might
be used quantitatively to measure binding of Mg2+ to the
enzyme. PA MS tryptophan ﬂuorescence increased hyperboli-
cally with an increase in Mg2+ concentration, as is typical of a
saturable binding system (Figure 6A). In the presence of
glyoxylate, the same Mg2+ titration also yielded a binding
isotherm, except that increasing Mg2+ concentrations led to
saturable quenching of ﬂuorescence (Figure 6A). Scatchard
analysis of the ﬂuorescence data yielded apparent Kd values for
the Mg2+−MS complex of 525 and 653 μM in the absence and
presence of glyoxylate, respectively (Figure 6B). This is
comparable with the binding aﬃnity of Mg2+ for other
enzymes.41
On the basis of sequence and structural similarity, we
propose that the amino acid residues involved in catalysis in PA
MS are Arg340, Glu432, Asp460, and Asp631 (Figures 2 and
3). We propose a mechanism, consistent with our ﬂuorescence
data and previous studies on MS in Mtb and E. coli,26−28,33 in
which Mg2+ is coordinated in an octahedral conformation by
the carboxylate side chains of Glu432 and Asp460, along with
four water molecules.39 In this model (Figure S7), glyoxylate
enters the active site and displaces two of the water molecules
in the Mg2+ coordination sphere. Following this, AcCoA enters
the active site. Asp631 then deprotonates AcCoA.38 The
resulting enolate attacks glyoxylate (activated by chelation of
Mg2+) to form a malyl-CoA intermediate that, in turn,
deprotonates a proximal water molecule. This aﬀords a
hydroxide anion that can attack and hydrolyze the thioester.
Arg340 then acts as a catalytic acid, protonating CoA, which
causes CoA to leave the active site ﬁrst, followed by malate.28
Identiﬁcation of Potential Binding Sites in PA MS.
Because PA is such a high-priority pathogen for new antibiotic
discovery eﬀorts, we wanted to identify any potential binding
sites in PA MS that might facilitate structure-based drug design.
Therefore, we analyzed the PA MS crystal structure using
Schrödinger’s SiteMap. We denoted the ﬁve top-ranking
potential binding sites identiﬁed by SiteMap as A−E, and
their SiteMap parameters are listed in Table 3. The location of
each site on the crystal structure is shown in Figure 7A as
colored mesh (site A, yellow; site B, orange; site C, magenta;
site D, blue; site E, cyan). Sites A−E possess a SiteScore of
>0.80, which is the minimum recommended value to
distinguish between a drug binding and non-drug binding
site.24 Site A is the top-ranked potential binding site with a
SiteScore of 1.10 and a Dscore of 1.16. Site B is second-ranked
with a SiteScore of 0.99 and a Dscore of 1.02.
These scores are consistent with those from earlier studies in
proteins in which drugs that bind with submicromolar aﬃnity
have been identiﬁed,24 indicating that sites A and B are
promising binding sites that could be used for structure-driven
drug design. Site A (Figure 7B) is narrow and highly
hydrophobic in nature, with a hydrophobic-to-hydrophilic
character ratio of 2.22. For reference, the mean hydrophobic-
to-hydrophilic ratio for tight binding sites in proteins is 1.60.24
This ratio, along with the SiteScore and Dscores calculated by
SiteMap, implies that this pocket is suitable for exploration
using druglike molecules. Also, because the pocket is located
deep within the protein, small molecules could be accom-
modated, rather than larger ones, whose entry may be hindered.
Site B has the largest predicted volume (569 Å3) and spreads
over the entrance of the active site. Site B has a hydrophobic
interior region and a hydrophilic exterior, with a hydrophobic-
to-hydrophilic character ratio of 0.61. The residues in site B are
displayed in Figure 7C.
Having identiﬁed potential ligand binding sites in PA MS, we
assessed the likely impact on enzyme function of binding of the
drug to these sites, and their degree of conservation across
species (including Mtb, PDB entry 5CC5; E. coli, PDB entry
1P7T; and M. leprae, PDB entry 4EX4). The protein structure
alignment revealed that site B incorporates the known substrate
binding sites of MS (Figure 8) and contains two of the residues
involved in catalysis in PA, Arg340 and Aps631, and the active
site ﬂuorophore, Trp539 (Figure 7C). Site A also partially
Figure 6. (A) Mg2+ binding curves in the presence (red) and absence
(blue) of 1 mM glyoxylate. Note that glyoxylate quenches the
tryptophan ﬂuorescence of P. aeruginosa malate synthase G in the
presence of Mg2+. Error bars correspond to ±1 standard deviation. (B)
Scatchard analysis of Mg2+ binding data.
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overlaps the substrate binding pocket, surrounding the β-
hairpin of domain II (amino acids 615−631), which borders the
active site.
Because of the structural conservation and functional
signiﬁcance of sites A and B, we looked for published inhibitors
of MS in other organisms that might bind in these sites. To
date, however, the few known inhibitors of MS solely target the
active site and are either glyoxylate analogues, Mg2+ chelators,
or endogenous metabolic intermediates.2,15,26,29,34−36
An example of such Mg2+ chelators is a class of compounds,
phenyldiketoacids (PDKA), that was discovered to inhibit Mtb
MS.4,35,36 Mtb MS complexed with the PDKA inhibitors did
not show signiﬁcant conformational changes; however, as seen
for ethylene glycol (EDO) in this work, the 1,2-diol moiety in
these inhibitors acts as a bidentate ligand of the Mg2+ in the
Mtb MS active site. Another example is a study in which a high-
throughput screen against PA grown on acetate identiﬁed small
molecule inhibitors of MS.15 In silico binding of these hits
following an induced-ﬁt docking procedure to homology
models of an Mtb MS crystal structure alluded to a likely
interaction with the active site Mg2+.
In a diﬀerent study of Mtb MS complexed with chemical
fragments, 18 fragments that formed a hydrogen bond with the
backbone carbonyl of Met631 in the active site were
identiﬁed.35 Met631 (Met629 in PA MS) is conserved in the
MS superfamily and is found in site A. The scarcity of PA MS
inhibitors highlights the potential of targeting it through
alternative binding pockets.
Computational Analysis of Structural Waters. The
solvation network in a crystal structure plays an important role
in determining protein−ligand binding aﬃnities. Our PA MS
crystal structure incorporates 691 water molecules per molecule
of MS, as opposed to 450 water molecules per molecule of Mtb
MS (PDB entry 1N8I). However, hydration networks are
dynamic, so we used the molecular dynamic simulator,
WaterMap, to better understand the possible impact of water
molecules on ligand binding. The location of the predicted
stable hydration sites was consistent with the observed
Table 3. SiteMap Parameters for Predicted Binding Sites A−E
site SiteScore size (no. of site points) Dscore volume (Å3) hydrophobic hydrophilic
site A 1.10 123 1.16 475.01 1.60 0.72
site B 0.99 188 1.02 569.03 0.58 0.95
site C 0.97 163 1.02 461.24 0.59 0.89
site D 0.96 110 0.97 269.12 0.50 1.06
site E 0.87 80 0.87 156.53 0.79 1.04
Figure 7. (A) Colored mesh represents the possible binding pockets predicted by SiteMap in P. aeruginosa malate synthase G (represented as a gray
cartoon): site A, yellow; site B, orange; site C, magenta; site D, blue; site E, cyan. Site A is located between a β-hairpin (amino acids 622−628) in
domain II and α-helices in the TIM barrel. Site B is composed of loops in the TIM barrel and domains II and III. Site C is located on the edge of the
protein between helix α1 in the N-terminal region and the ﬁnal α-helix of the protein at the C-terminus, along with a β-hairpin (amino acids 345−
350) from the TIM barrel. Site D is composed of a loop in the N-terminal region and α-helices in the TIM barrel. Site E sits near the loops of the N-
terminus and C-terminus, and a ﬂexible loop in the TIM barrel. (B) Site A is a hydrophobic pocket, and the binding site residues are shown as sticks.
(C) The polar and hydrophobic residues of site B are shown as sticks. These include the Arg340 and Asp631 amino acid side chains involved in
catalysis and the active site ﬂuorophore, Trp539.
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crystallographic waters (a snapshot of the active site water
molecules is shown in Figure 9).
The hydration sites predicted by WaterMap gave additional
insights into the thermodynamics of the solvation network
(Figure 10). The water molecules in the hydration sites colored
green are high-energy water molecules. Typically, these water
molecules are favorable for binding, and ligands that displace
these water molecules must compensate for this free energy
loss. Thus, it is better to avoid these sites during ligand design.
Conversely, hydration sites colored red/brown portray lower-
energy sites or unfavorable sites. Thus, replacing these water
molecules should favor an increase in free energy. WaterMap
also predicts cavity regions that are devoid of water molecules,
so targeting these regions may help in the search for high-
aﬃnity binders.
The WaterMap analysis conﬁrmed the top-ranked predicted
binding sites, A and B (Table 3), as druggable. WaterMap
(Figure 10A) revealed cavity regions along with unstable
hydration sites in sites A (Figure 10B) and B (Figure 10C).
The thermodynamic parameters associated with the hydration
sites shown in panels B and C of Figure 10 are provided in
Table S1. Site B has fewer unstable hydration sites than site A
does, which supports the hydrophilic nature of the pocket. In
contrast, site A is more hydrophobic. However, the unstable
hydration sites in site A are not continuous, suggesting that a
large molecule with several hydrophobic regions would be
required to ﬁt in neatly.
One particularly interesting cavity is located near the AcCoA
binding site (blue mesh in Figure 10C). This cavity is seen to
bind a hydrophobic small molecule [indole-3-carboxylic acid
(ICO)] in Mtb MS (PDB entry 5CC5). In that structure, ICO
occupies the space between the glyoxylate and AcCoA binding
sites (Figure 11), corresponding to the exact cavity identiﬁed
here in PA MS.
■ CONCLUSIONS
The need for new antibacterial agents against P. aeruginosa is
now critical. Because of the importance of the glyoxylate shunt
for persistence in infection scenarios, we have characterized the
structure and properties of P. aeruginosa malate synthase G,
with a special emphasis on identifying potential drug binding
sites. We report the ﬁrst X-ray crystal structure of P. aeruginosa
malate synthase G in the apo form at 1.62 Å resolution. We
used the crystal structure to inﬂuence experimentation, and we
show that events in the enzyme active site can be monitored
non-invasively using intrinsic tryptophan ﬂuorescence as a
probe. Our computational data reveal two sites in the structure
that are promising for drug development as well as the
thermodynamic properties of hydration sites within the
predicted binding sites. Our ﬁndings contribute to the growing
body of evidence that malate synthase G is a tractable drug
target and provide a means for inhibitor development against P.
aeruginosa using structure-based approaches.
Figure 8. Alignment of malate synthase G crystal structures (gray, P. aeruginosa; green, E. coli; cyan, M. tuberculosis; orange, M. leprae). Predicted
binding site A is shown in orange mesh with substrates glyoxylate and AcCoA (shown as sticks).
Figure 9. Hydration sites (brown spheres representing unstable water
molecules and green spheres representing stable water molecules)
predicted by WaterMap superposed with malate synthase G crystal
waters (cyan spheres). Catalytic amino acid residues (Arg340, Glu432,
and Asp631) are shown as sticks.
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Figure 11. Cavity map predicted by WaterMap (blue mesh). Indole-3-
carboxylic acid (ICO), which partially occupies the cavity region in M.
tuberculosis malate synthase G (PDB entry 5CC5), is shown as green
sticks. Substrates glyoxylate (teal sticks) and AcCoA (cyan sticks) from
PDB entry 1P7T are also presented to illustrate the binding location.
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